Serum levels of bone-origin alkaline phosphatase and of tartrate-resistant acid phosphatase were measured in Caucasian women aged 41–69 years who had volunteered for bone densitometry. Bone alkaline phosphatase and tartrate-resistant acid phosphatase were inversely correlated with vertebral bone density and with femoral neck bone density. Bone alkaline phosphatase and acid phosphatase were also significantly correlated, consistent with the concept of ‘coupling’ between osteoblast and osteoclast activity.
MartinTJNgKWNicholsonGC. Cell biology of bone. In: MartinTJ ed. Baillieres Clinical Endocrinology and Metabolism, Vol. 2. London: Bailliere Tindall1988: 1–29.
6.
DelmasPD. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. In: In: Tiegs RD, ed. Endocrinol Metab Clin North Am1990; 19: 1–18.
7.
FrostHM. Tetracycline-based histological analysis of bone remodelling. Calc Tiss Int1969; 3: 211–37.
8.
FrostHM. The pathomechanics of osteoporosis. Clin Orthop1985; 200: 198–225.
9.
ChristiansenCRiisBJRodbroP. Prediction of rapid bone loss in women. Lancet1987; i: 1105–8.
10.
RosalkiSBFooAY. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem1984; 30: 1182–6.
11.
TietzNWRinkerADShawLM. IFCC methods for the measurement of catalytic concentrations of enzymes Part 5. IFCC method for alkaline phosphatase (orthophosphoric monoester phospho-hydrolase, alkaline optimum, EC 3.1.3.1). J Clin Chem Clin Biochem1983; 21: 731–48.
12.
AnderschMASczpinskiC. Use of p-nitrophenol phosphate as substrate in determination of serum acid phosphatase. Am J Clin Pathol1947; 17: 571–4.
13.
FishmanWHLernerF. A method for estimating serum acid phosphatase of prostatic origin. J Biol Chem1953; 200: 89–97.
14.
HansenJWGordanGSPrussinSG. Direct measurement of osteolysis in man. J Clin Invest1973; 52: 304–15.
O'CarrollDStatlandBESteeleBWBurkeMD. Chemical inhibition method for alkaline phosphatase isoenzymes in human sera. Am J Clin Pathol1975; 63: 564–72.
19.
SharlandDE. Alkaline phosphatase: The isoenzyme pattern in the elderly and changes in total serum levels with age. Clin Chim Acta1974; 56: 187–98.
20.
WhitakerKBWhitbyLCMossDW. Activities of bone and liver alkaline phosphatases in serum in health and disease. Clin Chim Acta1977; 80: 209–20.
21.
EpsteinSPoserJMcClintockRMJohnstonCCBryceGHinS. Differences in serum bone GLA-protein with age and sex. Lancet1984; i: 307–10.
22.
DelmasPDStennerDWahnerHWMannKGRiggsBL. Increases in serum bone GLA-protein with ageing in women: Implications for the mechanism of age-related bone loss. J Clin Invest1983; 71: 1316–21.
23.
DelmasPDWahnerHWMannKGRiggsBL. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone GLA-protein. J Lab Clin Med1983; 102: 470–6.
24.
YasumuraSAloiaJGundbergCMYehJVaswainANYuenKSerum osteocalcin and total body calcium in normal pre- and postmenopausal women and postmenopausal osteoporotic patients. J Clin Endocrinol Metab1987; 64: 681–5.
25.
RiggsBLWahnerHWDunnWLMazessRBOffordKPMeltonLJ. Differential changes in bone mineral density of the appendicular and axial skeleton with ageing: Relationship to spinal osteoporosis. J Clin Invest1981; 67: 328–35.
26.
HansenMAOvergaardKChristiansenC. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study. BMJ1991; 303: 961–4.
